vs

Side-by-side financial comparison of Real Brokerage Inc (REAX) and StepStone Group Inc. (STEP). Click either name above to swap in a different company.

StepStone Group Inc. is the larger business by last-quarter revenue ($586.5M vs $568.5M, roughly 1.0× Real Brokerage Inc). Real Brokerage Inc runs the higher net margin — -0.1% vs -21.0%, a 21.0% gap on every dollar of revenue. On growth, StepStone Group Inc. posted the faster year-over-year revenue change (73.0% vs 52.6%). StepStone Group Inc. produced more free cash flow last quarter ($26.7M vs $8.4M).

Anywhere Real Estate Inc., formerly Realogy, was an American real estate services firm. It operated and franchised real estate brands that provided brokerage, relocation, title, insurance, and settlement services. Brands included Better Homes and Gardens Real Estate, Century 21 Real Estate, Coldwell Banker, Corcoran Group, ERA Real Estate and Sotheby's International Realty. In 2026, the company was acquired by Compass, Inc.

Rosetta Stone Inc. is an American education technology software company that develops language, literacy and brain-fitness software. Best known for its language-learning products, in 2013, the company expanded beyond language into education-technology with its acquisitions of Livemocha, Lexia Learning, Fit Brains, and Tell Me More. In 2021, it became a subsidiary of IXL Learning.

REAX vs STEP — Head-to-Head

Bigger by revenue
STEP
STEP
1.0× larger
STEP
$586.5M
$568.5M
REAX
Growing faster (revenue YoY)
STEP
STEP
+20.4% gap
STEP
73.0%
52.6%
REAX
Higher net margin
REAX
REAX
21.0% more per $
REAX
-0.1%
-21.0%
STEP
More free cash flow
STEP
STEP
$18.3M more FCF
STEP
$26.7M
$8.4M
REAX

Income Statement — Q3 FY2025 vs Q3 FY2026

Metric
REAX
REAX
STEP
STEP
Revenue
$568.5M
$586.5M
Net Profit
$-447.0K
$-123.5M
Gross Margin
7.9%
Operating Margin
-0.1%
-33.2%
Net Margin
-0.1%
-21.0%
Revenue YoY
52.6%
73.0%
Net Profit YoY
82.7%
35.7%
EPS (diluted)
$0.00
$-1.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
REAX
REAX
STEP
STEP
Q4 25
$586.5M
Q3 25
$568.5M
$454.2M
Q2 25
$540.7M
$364.3M
Q1 25
$354.0M
$377.7M
Q4 24
$339.0M
Q3 24
$372.5M
$271.7M
Q2 24
$186.4M
Q1 24
$200.7M
$356.8M
Net Profit
REAX
REAX
STEP
STEP
Q4 25
$-123.5M
Q3 25
$-447.0K
$-366.1M
Q2 25
$1.5M
$-38.4M
Q1 25
$-5.0M
$-18.5M
Q4 24
$-192.0M
Q3 24
$-2.6M
$17.6M
Q2 24
$13.3M
Q1 24
$-16.1M
$30.8M
Gross Margin
REAX
REAX
STEP
STEP
Q4 25
Q3 25
7.9%
Q2 25
8.9%
Q1 25
9.6%
Q4 24
Q3 24
8.6%
Q2 24
Q1 24
10.3%
Operating Margin
REAX
REAX
STEP
STEP
Q4 25
-33.2%
Q3 25
-0.1%
-148.8%
Q2 25
0.3%
-5.6%
Q1 25
-1.5%
2.6%
Q4 24
-101.7%
Q3 24
-0.7%
21.3%
Q2 24
29.4%
Q1 24
-7.8%
26.5%
Net Margin
REAX
REAX
STEP
STEP
Q4 25
-21.0%
Q3 25
-0.1%
-80.6%
Q2 25
0.3%
-10.5%
Q1 25
-1.4%
-4.9%
Q4 24
-56.6%
Q3 24
-0.7%
6.5%
Q2 24
7.2%
Q1 24
-8.0%
8.6%
EPS (diluted)
REAX
REAX
STEP
STEP
Q4 25
$-1.55
Q3 25
$0.00
$-4.66
Q2 25
$0.01
$-0.49
Q1 25
$-0.02
$-0.37
Q4 24
$-2.61
Q3 24
$-0.01
$0.26
Q2 24
$0.20
Q1 24
$-0.09
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
REAX
REAX
STEP
STEP
Cash + ST InvestmentsLiquidity on hand
$38.7M
Total DebtLower is stronger
$270.2M
Stockholders' EquityBook value
$53.6M
$-378.8M
Total Assets
$145.2M
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
REAX
REAX
STEP
STEP
Q4 25
Q3 25
$38.7M
Q2 25
$49.7M
Q1 25
$24.7M
Q4 24
Q3 24
$22.6M
Q2 24
Q1 24
$20.1M
Total Debt
REAX
REAX
STEP
STEP
Q4 25
$270.2M
Q3 25
$269.9M
Q2 25
$269.6M
Q1 25
$269.3M
Q4 24
$168.9M
Q3 24
$172.3M
Q2 24
$172.1M
Q1 24
$148.8M
Stockholders' Equity
REAX
REAX
STEP
STEP
Q4 25
$-378.8M
Q3 25
$53.6M
$-233.5M
Q2 25
$49.2M
$153.9M
Q1 25
$32.8M
$179.4M
Q4 24
$209.8M
Q3 24
$29.8M
$397.5M
Q2 24
$366.9M
Q1 24
$25.6M
$324.5M
Total Assets
REAX
REAX
STEP
STEP
Q4 25
$5.2B
Q3 25
$145.2M
$5.3B
Q2 25
$149.4M
$4.8B
Q1 25
$100.5M
$4.6B
Q4 24
$4.3B
Q3 24
$102.5M
$4.0B
Q2 24
$3.8B
Q1 24
$3.8B
Debt / Equity
REAX
REAX
STEP
STEP
Q4 25
Q3 25
Q2 25
1.75×
Q1 25
1.50×
Q4 24
0.81×
Q3 24
0.43×
Q2 24
0.47×
Q1 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
REAX
REAX
STEP
STEP
Operating Cash FlowLast quarter
$8.8M
$27.2M
Free Cash FlowOCF − Capex
$8.4M
$26.7M
FCF MarginFCF / Revenue
1.5%
4.6%
Capex IntensityCapex / Revenue
0.1%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$71.7M
$18.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
REAX
REAX
STEP
STEP
Q4 25
$27.2M
Q3 25
$8.8M
$16.2M
Q2 25
$41.0M
$46.3M
Q1 25
$15.9M
$-66.5M
Q4 24
$27.6M
Q3 24
$7.2M
$53.7M
Q2 24
$50.2M
Q1 24
$21.5M
$7.6M
Free Cash Flow
REAX
REAX
STEP
STEP
Q4 25
$26.7M
Q3 25
$8.4M
$15.9M
Q2 25
$40.8M
$45.2M
Q1 25
$15.7M
$-69.2M
Q4 24
$27.0M
Q3 24
$6.8M
$52.4M
Q2 24
$49.6M
Q1 24
$21.4M
$6.7M
FCF Margin
REAX
REAX
STEP
STEP
Q4 25
4.6%
Q3 25
1.5%
3.5%
Q2 25
7.5%
12.4%
Q1 25
4.4%
-18.3%
Q4 24
8.0%
Q3 24
1.8%
19.3%
Q2 24
26.6%
Q1 24
10.7%
1.9%
Capex Intensity
REAX
REAX
STEP
STEP
Q4 25
0.1%
Q3 25
0.1%
0.1%
Q2 25
0.0%
0.3%
Q1 25
0.1%
0.7%
Q4 24
0.2%
Q3 24
0.1%
0.5%
Q2 24
0.3%
Q1 24
0.0%
0.3%
Cash Conversion
REAX
REAX
STEP
STEP
Q4 25
Q3 25
Q2 25
27.13×
Q1 25
Q4 24
Q3 24
3.05×
Q2 24
3.76×
Q1 24
0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

REAX
REAX

Segment breakdown not available.

STEP
STEP

Other$210.1M36%
Management And Advisory Fees Net Focused Commingled Funds$143.3M24%
Carried Interest Allocation Focused Commingled Funds$85.1M15%
Carried Interest Allocation Separately Managed Accounts$63.6M11%
Carried Interest Allocation Realized$46.7M8%
Management And Advisory Fees Net Advisory And Other Services$18.3M3%
Legacy Carried Interest Allocation Focused Commingled Funds$10.3M2%
Income Based Incentive Fees$6.0M1%
Management And Advisory Fees Net Fund Reimbursement Revenues$3.1M1%

Related Comparisons